In particular, the NDRG1, HK2, PLOD2, EGLN3, and NPC1 genes showed a higher expression in tumors than in normal tissues, and cervical cancer patients overexpressing these genes had a poor prognosis compared with those who showed low expression levels of these genes (Figure 6b,c). This evidence concerns the gene PLOD2 and cervical carcinoma.